Soufflé Therapeutics Funding: $200M Raised, Series A (2025)

Soufflé Therapeutics funding overview

Soufflé Therapeutics is a Biotech company based in Watertown. Soufflé Therapeutics has raised $200M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in October 2025. The round record for Soufflé Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include Polaris Partners, Bessemer Venture Partners, ARCH Venture Partners, Vida Ventures, Temasek, Leaps by Bayer and 1 others. 7 distinct backers are named across the disclosed rounds.

Soufflé Therapeutics at a glance

Total raised: $200M
Latest round: Series A
Latest round date: October 2025
Industry: Biotech
Headquarters: Watertown
Notable investors: Polaris Partners, Bessemer Venture Partners, ARCH Venture Partners, Vida Ventures, Temasek, Leaps by Bayer, AbbVie

Frequently asked about Soufflé Therapeutics funding

How much has Soufflé Therapeutics raised?: Soufflé Therapeutics has raised $200M in total disclosed funding across the rounds on record.
Who has invested in Soufflé Therapeutics?: Polaris Partners, Bessemer Venture Partners, ARCH Venture Partners, Vida Ventures, Temasek, Leaps by Bayer are named among the investors backing Soufflé Therapeutics.
What was the latest Soufflé Therapeutics funding round?: The most recent disclosed round is a Series A, announced in October 2025.
Where is Soufflé Therapeutics based?: Soufflé Therapeutics is based in Watertown.
What sector does Soufflé Therapeutics operate in?: Soufflé Therapeutics is tracked under Biotech from Watertown, with $200M in disclosed funding.
When did Soufflé Therapeutics last raise?: The last disclosed Soufflé Therapeutics round closed in October 2025 at Series A.

Soufflé Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in Watertown below to benchmark round size and investor mix.

Soufflé Therapeutics Funding: $200M Raised, Series A (2025)

Soufflé Therapeutics funding overview

Soufflé Therapeutics at a glance

Frequently asked about Soufflé Therapeutics funding

Soufflé Therapeutics founders (1)

Companies related to Soufflé Therapeutics (40)

Browse related funding lists (8)